Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study
Archives of Dermatological Research · 2025
DOI: 10.1007/s00403-025-04090-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Giuseppina Caiazzo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Biomedical Sciences, University of Naples Federico II, Napoli, Italy. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Napoli Federico II.
Abstract (Originalsprache)
Atopic dermatitis is a chronic inflammatory systemic disease that can persist or start in adulthood, even in elderly age, with several clinical phenotypes. The aim of this study was to evaluate the relationship between phenotype and endotype in elderly patients, and the long-term effects of dupilumab on molecular signature in these patients. A total of 50 elderly patients had been treated with dupilumab during the follow up period. Regarding effectiveness parameters, mean EASI score at Week 0 was 25.12 ± 4.23 and significantly reduced to 2.42 ± 3.15 at Week 52 ( p < 0.05). Regarding safety, none of the registered adverse events led to the discontinuation of dupilumab therapy. Moreover, after 52 weeks of dupilumab treatment, Th2 cytokines expression was decreased, with IL-13 and IL-31 downregulated in both patient groups at Week 52, at both gene and protein levels when compared with Week 0. Our data also revealed a significant increase in both IL-4 gene expression and protein production at Week 52 when compared with Week 0. Unexpectedly, our results also revealed that IL-22 cutaneous expression was significantly increased, while circulating levels were decreased at Week 52 when compared to Week 0. In conclusion, our results highlight the effectiveness of dupilumab at a late time point as Week 52. Of note, a dumping of the Th2- and Th17- immune response at both systemic and in situ level and a possible remodelling role of IL-22 in the skin is suggested.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Advanced Biomedical Sciences, University of Naples Federico II, Napoli, Italy.
- Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
- Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. vince.picone95@gmail.com.
- Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy.
Förderung
- Università degli Studi di Napoli Federico II
Zitieren
APA
Caiazzo, G., Napolitano, M., Quaranta, M., Picone, V., Fabbrocini, G., & Patruno, C. (2025). Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04090-5
Vancouver
Caiazzo G, Napolitano M, Quaranta M, Picone V, Fabbrocini G, Patruno C. Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04090-5
BibTeX
@article{Caiazzo2025,
author = {Caiazzo, Giuseppina and Napolitano, Maddalena and Quaranta, Maria and Picone, Vincenzo and Fabbrocini, Gabriella and Patruno, Cataldo},
title = {Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study},
journal = {Archives of Dermatological Research},
year = {2025},
doi = {10.1007/s00403-025-04090-5}
}
EUVIMED